Has Ania Molina received payments from drug or device companies?

Yes. Drug and device makers reported $4,985 in general payments to Ania Molina across 216 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ania Molina did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ania Molina come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ania Molina

Psychiatric/Mental Health · Miami, FLNPI 1225791577

Payments from drug & device makers

$4,985in general payments, 2019–2025

Across 216 payments — averaging $23.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Otsuka America Pharmaceutical, Inc.$3K
AbbVie$1K
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$340
Alkermes, Inc.$331
Axsome Therapeutics, Inc.$249
Lundbeck LLC$126
plus $209 from 5 others

What the payments were for

Food & beverage$4,985100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Otsuka America Pharmaceutical, Inc.	88	$2,513
AbbVie	72	$1,217
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	16	$340
Alkermes, Inc.	17	$331
Axsome Therapeutics, Inc.	9	$249
Lundbeck LLC	5	$126
Almatica Pharma LLC	3	$70
Takeda Pharmaceuticals U.S.A., Inc.	2	$52
E.r. Squibb & Sons, L.L.C.	2	$46
Neurocrine Biosciences, Inc.	1	$21
Teva Pharmaceuticals USA, Inc.	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,985 in reported general payments places this provider in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
RexultiBrexpiprazole	98	$149,733
VraylarCariprazine Hcl	12	$16,900
TrintellixVortioxetine Hydrobromide	31	$14,955
Duloxetine Hcl	1,014	$13,015
Escitalopram Oxalate	1,820	$8,434
Mirtazapine	840	$8,087
Buspirone Hcl	1,449	$6,468
BelsomraSuvorexant	14	$6,131
Quetiapine Fumarate	822	$5,724
Lurasidone Hcl	21	$5,446
Trazodone Hcl	1,868	$5,398
Temazepam	246	$4,131
Aripiprazole	204	$4,086
Clonazepam	992	$3,482
Memantine Hcl	483	$2,802

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti	$2,513	$149,73398 claims
AbbVieVraylar	$1,217	$16,90012 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix	$52	$14,95531 claims
Almatica Pharma LLCSertraline Hcl	$70	$2,5381,152 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Miami

Carlos LarrauriMiami$23K
Sandra Pelaez-MurseyMiami$20K
Rolando Gonzalez AriasMiami$18K
Roger RiveraKissimmee$1.6M
Bethanie Simmons BecilJacksonville$782K
Hannah PhillipsMaitland$455K
Cheedy JajaTampa$266K
Scott DurrancePensacola$224K
Eudaldo AponteHialeah$214K
Heather WarrenTallahassee$172K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →